FTV Fortive
Asset-light post-spin Fortive throws off cash; fair value near market, little margin of safety.
The story
Post-Ralliant-spin Fortive is a leaner portfolio of software-enabled industrial tools (Fluke, Tektronix-adjacent instrumentation, Gordian/Accruent software, ASP sterilization). It has sticky installed bases, a high-margin recurring software mix and a strong Fortive Business System culture. As a mature, cash-generative compounder, it grows low-to-mid single digits organically, boosted by bolt-on M&A and heavy buybacks.
TTM revenue (+5.8%) and operating margin (19.8%, up from 17.4%) confirm the post-spin margin story, so I nudge target margin to 24%. Sales-to-capital moves materially from 0.9 to 2.0: the 0.46 reported figure is inflated by goodwill from past acquisitions, while capex ($0.07B against $0.45B D&A) shows organic reinvestment needs are light. My prior value (27.66) sat more than 50% below a market price backed by a roughly 4.5% FCF-to-EV yield, which signaled that this driver was too punitive.
Value drivers
| Revenue growth (Y1) | 5.5% |
| Terminal growth | 3.0% |
| Forecast horizon | 7y |
| Target operating margin | 24.0% |
| Years to target margin | 6 |
| Sales-to-capital | 2.00 |
| Beta | 1.05 |
| Failure probability | 2.0% |
| Cost of capital (WACC) | 9.1% |
| Terminal WACC | 8.9% |
Valuation bridge
| PV of explicit FCFF | 4.63B |
| PV of terminal value | 7.81B |
| Equity value | 9.41B |
| ÷ shares → per share | $31.63 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 4.64B | 5.5% | 20.5% | 839.93M | 120.90M | 719.04M | 658.89M |
| 2 | 4.87B | 5.1% | 21.2% | 913.04M | 117.88M | 795.16M | 667.70M |
| 3 | 5.10B | 4.7% | 21.9% | 987.49M | 113.72M | 873.77M | 672.33M |
| 4 | 5.32B | 4.2% | 22.6% | 1.06B | 108.40M | 954.24M | 672.83M |
| 5 | 5.52B | 3.8% | 23.3% | 1.14B | 101.93M | 1.04B | 669.32M |
| 6 | 5.71B | 3.4% | 24.0% | 1.21B | 94.33M | 1.12B | 661.94M |
| 7 | 5.88B | 3.0% | 24.0% | 1.25B | 85.66M | 1.16B | 631.01M |
Key risks
- Industrial/capex cycle softness hitting Fluke and instrumentation volumes
- Value-destructive or overpriced M&A as growth substitute
- Healthcare/software segment growth stalling, eroding the multiple premium
Catalysts
- Continued margin expansion and buyback-driven EPS growth post-spin
- Recovery in industrial demand lifting organic growth toward 4-5%